We could not find any results for:
Make sure your spelling is correct or try broadening your search.
BERLIN, Germany, January 19 /PRNewswire-FirstCall/ -- Bayer Schering Pharma AG (NYSE:SHR) has signed a license and option agreement with Taisho Pharmaceutical Co., Ltd., Nihon Nohyaku Co., Ltd...
Squeeze-out of Schering's Minority Shareholders BERLIN and LEVERKUSEN, Germany, December 5 /PRNewswire-FirstCall/ -- Bayer plans to acquire the remaining outstanding shares of Schering AG...
BERLIN, November 28 /PRNewswire-FirstCall/ -- Schering AG, Germany (FSE: SCH), majority-owned by the Bayer Group, and Stanford University, California, USA have started a joint research program...
- Net Sales: +9% - Operating Profit: +20% (adjusted for one-time effects) - Betaferon(R): +16% Schering AG, Germany (FSE: SCH) continued to grow strongly during the first nine months of...
NEW YORK and BERLIN and LEVERKUSEN, Germany, November 24 /PRNewswire-FirstCall/ -- The New York Stock Exchange (NYSE) has decided to suspend trading in Schering American Depositary Receipts...
BERLIN, November 23 /PRNewswire-FirstCall/ -- Schering AG, Germany (FSE: SCH, NYSE: SHR), majority-owned by the Bayer Group, announced today that the Australian Therapeutic Goods Administration...
EUR 89.36 Cash Compensation Offer to Schering's Outside Stockholders BERLIN and LEVERKUSEN, Germany, November 8 /PRNewswire-FirstCall/ -- The way is now clear for Schering AG (NYSE:SHR) to be...
- Twenty-five study centers currently open across the U.S. - WAYNE, N.J., Oct. 31 /PRNewswire/ -- Berlex Oncology, a business unit of Berlex Laboratories, a U.S. affiliate of Schering AG...
BERLIN and LEVERKUSEN, Germany, October 30 /PRNewswire-FirstCall/ -- Following the consent of the Extraordinary Stockholders' Meeting of Schering AG (NYSE:SHR) on September 13, 2006 to the...
Early Treatment With Betaseron Significantly Delayed the Time to a Second Clinical Event - Video Available WAYNE, N.J., Oct. 23 /PRNewswire/ -- Berlex, Inc., a U.S. affiliate of Schering AG...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions